Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
COVID vaccine effective for 90% of cancer patients, Israeli study finds | The Times of Israel
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
First-of-its-kind study in Israel finds that cancer patients are safe for COVID-19 vaccines - EJP
Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs | The Times of Israel
Leadership – CTG-Pharma
Stotsky Professorship - Jewish Studies Program
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Transnational cancer research lab | Felsenstein Medical Research Center
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
COVID vaccine effective for 90% of cancer patients, Israeli study finds | The Times of Israel
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
